Abstract. We describe a female child with pituitary gigantism and precocious adrenarche. From two years of age she showed unusual overgrowth, and at 5 years old she was 133.5 cm (+ 5.5 SD) tall and weighed 40.5 kg. Her precocious manifestations were pubic hair, acne vulgaris, hirsutism, and advanced bone age. Endocrinological examination revealed markedly increased serum growth hormone (GH) and prolactin (PRL), which responded paradoxically to a TRH test. In addition, the concentrations of serum dehydroepiandrosterone (DHA) and its sulfate (DHAS) were increased to adult levels, moving in accordance with changes in ACTH, which suggested that these androgens were secreted from the adrenal glands functionally. These androgens seemed to be responsible for her partial precocity. Prior reports have suggested that GH and/or PRL overproduction might have played a role in the induction of adrenarche. Also, in previous reports of 9 gigantism patients under 10 years old, the manifestation of precocious adrenarche was suggested in 8. Further investigation of the influence of GH and PRL on adrenal androgen production in children with pituitary gigantism is required. On the other hand, in short children with normal GH secretion, attention should be paid to whether or not the GH therapy in early childhood induces precocious adrenarche.
LITTLE IS known about the mechanism of the activation of adrenal androgen secretion in childhood, referred to as adrenarche. Although the production of these androgens is stimulated by ACTH, ACTH may not be the sole factor regulating adrenarche. Several investigators have suggested that factors other than ACTH are involved in the control of adrenal androgen production. However, the nature of these agents remains a matter of controversy.
The gigantism child presented here, with pituitary adenoma secreting both GH and PRL, was associated with precocious adrenarche. GH is a major hormone promoting linear growth in childhood; however, it also has various other biological effects in vivo. Again, the physiological significance of PRL is not fully known. Although gigantism due to pituitary adenoma in childhood is a rare disorder, the patient provides much significant information for elucidating the biological effects of GH and/or PRL in childhood. In this report, we describe in detail the results of endocrinological studies in this gigantism case. Further, we review previous reports of pituitary gigantism children [1] [2] [3] [4] [5] [6] [7] [8] , and discuss the still unknown mechanism of adrenarchal onset.
Subject and Methods

Subject (Case Report)
The subject was a 12.6-year-old girl who was tration also remained at a prepubertal level (Table  1) . At 12.6 years of age, we evaluated her pituitary function again. Although basal GH had decreased to a level slightly higher than normal, the serum GH still showed a paradoxical response to TRH administration (Table 2C) . Furthermore, in an OGTT, the GH level was not suppressed significantly, but maintained a slightly higher than normal level. LH and FSH responded to an LH-RH test better than previously (Table 2B ), but the pituitary-gonadal function did not develop to the pubertal level because the serum estradiol level remained below 10 pg/ml (Table 1) .
Discussion
The adrenarche, an increase in adrenal androgens, does not occur in early childhood [10] [11] [12] ; however, serum DHA and DHAS of this patient had already increased to adult levels at 6 years of age. By means of ACTH and dexamethasone suppression tests performed at 6 years of age, we confirmed that the origin of the androgens, DHA and DHAS, was the adrenal glands, because the movement of these steroids was dependent on changes in ACTH (Figs. 1 and 2) . Furthermore, the results of adrenal scintigraphy also indicated that the origin of these androgens was the adrenals.
Although DHAS is the most abundant steroid circulating in the plasma of normal human adults, its biological role is not fully known. Some reports have suggested that DHAS may possess weak androgenic and estrogenic activities [13] , and that the adrenarche may be related to the pubic hair growth [14, 15] . Our patient exhibited the following noticeable manifestations at 5 and 6 years of age: pubic hair, acne vulgaris, hirsutism of the legs, and advanced bone age, which can be considered a reflection of androgenic and/or estrogenic effects. It seems unlikely that these findings resulted from the effects of pituitarygonadal axis activation, because gonadotropin response to an LH-RH test remained at a prepubertal level and the serum estradiol concentration also remained low (Tables 1 and 2A) . Therefore, increased adrenal androgens should be responsible for her partial precocity and bone age acceleration.
The onset mechanism of adrenarche remains uncertain.
The existence of a pituitary adrenal androgen-stimulating hormone (AASH), which acts in the presence of ACTH to stimulate and control the secretion of adrenal androgens, has been postulated [16] [17] [18] . On the other hand, some researchers do not agree that there is such a factor and have suggested that adrenarche results from a shift in the pathway of steroid synthesis in response to the ACTH stimulation that follows the development of the zona reticularis [19] . However, it is still not known what factor develops the zona reticularis and causes adrenarche. Does pituitary gigantism associated with precocious adrenarche, as observed in our patient, suggest a relationship between GH and/or PRL AND ADRENARCHE 255 and adrenarchal onset? Pituitary gigantism in early childhood is exceedingly rare, and most patients show overproduction of both GH and PRL. In our review of the literature, we could find as case reports only nine cases under 10 years old who were not associated with McCune-Albright syndrome, and eight of the nine reports included a description of pubertal signs and evaluations of gonadotropins or steroid hormones [1] [2] [3] [4] [5] [6] [7] [8] . Eight out of nine cases, including our patient, exhibited pubic hair or increased urinary 17-KS without other pubertal signs or any gonadotropin or sex hormone increase (Table 3) . Unfortunately, except for our patient, none of their DHA or DHAS was measured, so there was no direct evidence of adrenarche. However, the findings of pubic hair and urinary 17-KS do not seem to be due to gonadal activation, and therefore suggest increased adrenal androgens. Hence, these clinical findings associated with pituitary gigantism indicate a possible relationship between GH and/or PRL and the induction of adrenarche.
This possibility is suggested by the following evidence. Carter et al. [20] and Schiebinger et al. [21] suggested that hyperprolactinemia was responsible for the stimulation of adrenal androgen production.
They reported that bromocriptine induced significant decreases in the serum PRL, DHA, and DHAS concentrations in hyperprolactinemic patients. The following observations also suggest the influence of PRL on adrenal function: adrenal tissue contains PRL receptors [22, 23] , and cultured human adrenal cortical cells exposed to PRL secrete more DHAS than do control cells [24] . GH may also stimulate the growth of the adrenal glands. Skottner et al. [25] observed augmentation of adrenal weight following their treatment of experimental rats with GH. Pillion et al. [26] and Shigematsu et al. [27] reported that IGF-I receptor is present in the human adrenal cortex, especially in the zona reticularis [26] . Further, in isolated GH deficient children, adrenarche does occur; however, a lower serum DHAS was observed than in the control group [28] . These results indicate that PRL and also GH, probably mediated by IGF-I, may contribute to the regulation of adrenal growth and function, and as a consequence play a role in adrenarchal onset. In our patient, to determine the influence of GH and PRL on adrenal androgen secretion, bromocriptine was administered for 5 days. It failed, however, to suppress the serum DHAS level or etiocholanolone excretion in the urine probably because serum GH and PRL concentrations were not reduced enough to influence DHAS secretion. As shown in Table 1 , despite the reduction in the GH baseline level after the third operation, the blood IGF-I and also the PRL concentrations were still abnormally high. These findings indicate that the residual pituitary adenoma was still active (Table 2C) , and this must be the cause of still high DHA and DHAS levels.
The mechanism of precocious adrenarche observed in the gigantism child appears complex. ACTH seems to be necessary to control adrenal androgen production. Further, the possibility of the participation of GH or PRL, or the synergic action of both, should be considered. Again, it is unclear whether or not GH/IGF-I and/or PRL contribute to the natural onset of adrenarche. However, the fact that child gigantism with GHand PRL-producing adenoma was associated with precocious adrenarche suggests that GH and/or PRL should be considered a possible causative factor(s) in adrenarchal onset. Our findings also invite attention to the GH treatment of short children.
The recent unlimited supply of GH preparation derived from recombinant DNA technology makes possible studies to assess the efficacy of exogenous GH for height gain in non-GHdeficient short children [29] [30] [31] , but such a treatment may induce precocious adrenarche.
Further investigation of the influence of GH and PRL on adrenal androgen production in children is required.
